| Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study |
18 |
| Changes in treatment and outcomes after creation of a pulmonary embolism response team (PERT), a 10-year analysis |
15 |
| The use of prophylactic anticoagulation during induction and consolidation chemotherapy in adults with acute lymphoblastic leukemia |
12 |
| Fixed dose 4-factor prothrombin complex concentrate for the emergent reversal of warfarin: a retrospective analysis |
11 |
| A meta-summary of case reports of non-vitamin K antagonist oral anticoagulant use in patients with left ventricular thrombus |
10 |
| A pulmonary embolism response team (PERT) approach: initial experience from the Cleveland Clinic |
9 |
| The impact of a pulmonary embolism response team on the efficiency of patient care in the emergency department |
8 |
| Tenecteplase versus alteplase for management of acute ischemic stroke: a pairwise and network meta-analysis of randomized clinical trials |
8 |
| Effects of body mass index on the safety and effectiveness of direct oral anticoagulants: a retrospective review |
8 |
| Characteristics of patients presenting with myocardial infarction with non-obstructive coronary arteries (MINOCA) in Poland: data from the ORPKI national registry |
7 |
| Bariatric surgery in morbidly obese individuals affects plasma levels of protein C and thrombomodulin |
7 |
| Direct oral anticoagulants: a review of common medication errors |
7 |
| Long-term performance of risk scores for venous thromboembolism in ambulatory cancer patients |
7 |
| Effectiveness and safety of non-vitamin-K antagonist oral anticoagulants versus warfarin in atrial fibrillation patients with thrombocytopenia |
7 |
| Outcomes associated with under-dosing of rivaroxaban for management of non-valvular atrial fibrillation in real-world Japanese clinical settings |
7 |
| Direct-acting oral anticoagulant drug level monitoring in clinical patient management |
7 |
| Do telehealth interventions improve oral anticoagulation management? A systematic review and meta-analysis |
7 |
| De-escalation from ticagrelor to clopidogrel in acute coronary syndrome patients: a systematic review and meta-analysis |
7 |
| Andexanet alfa to reverse the anticoagulant activity of factor Xa inhibitors: a review of design, development and potential place in therapy |
6 |
| The comparative analysis of non-thrombotic internal jugular vein stenosis and cerebral venous sinus stenosis |
6 |
| Is acute pulmonary embolism more severe in the presence of obstructive sleep apnea? Results from an observational cohort study |
6 |
| Appropriateness of direct oral anticoagulant dosing and its relation to drug levels in atrial fibrillation patients |
6 |
| Assessment of the reporting quality of RCTs for novel oral anticoagulants in venous thromboembolic disease based on the CONSORT statement |
6 |
| Clopidogrel and aspirin after ischemic stroke or transient ischemic attack: an updated systematic review and meta-analysis of randomized clinical trials |
6 |
| Structure and function of anticoagulation clinics in the United States: an AC forum membership survey |
6 |
| Comparison between two-point and three-point compression ultrasound for the diagnosis of deep vein thrombosis |
6 |
| Medicinal plants with antithrombotic property in Persian medicine: a mechanistic review |
6 |
| Restrictive versus liberal red blood cell transfusion for cardiac surgery: a systematic review and meta-analysis of randomized controlled trials |
5 |
| Blueprinting thrombogenicity and antithrombotic drug response at the bedside in patients presenting emergently with symptoms of acute stroke |
5 |
| Treatment of submassive and massive pulmonary embolism: a clinical practice survey from the second annual meeting of the Pulmonary Embolism Response Team Consortium |
5 |
| Anticoagulation prescribing patterns in patients with cancer |
5 |
| Thrombin generation test as a marker for high risk venous thrombosis pregnancies |
5 |
| Gender differences in thrombogenicity among patients with angina and non-obstructive coronary artery disease |
5 |
| Efficacy and safety of rivaroxaban on the resolution of left atrial/left atrial appendage thrombus in nonvalvular atrial fibrillation patients |
5 |
| Efficacy and safety of dabigatran in patients with atrial fibrillation scheduled for transoesophageal echocardiogram-guided direct electrical current cardioversion: a prospective propensity score-matched cohort study |
5 |
| Laboratory measurement of apixaban using anti-factor Xa assays in acute ischemic stroke patients with non-valvular atrial fibrillation |
5 |
| Efficacy and safety of outpatient treatment with direct oral anticoagulation in pulmonary embolism |
5 |
| A narrative review of the cardiovascular risks associated with concomitant aspirin and NSAID use |
5 |
| How to perform and manage low-dose and slow/ultra-slow tissue type plasminogen activator infusion regimens in patients with prosthetic valve thrombosis |
5 |
| Drug interaction as a predictor of direct oral anticoagulant drug levels in atrial fibrillation patients |
5 |
| Clinical implications of different risk factor profiles in patients with mesenteric venous thrombosis and systemic venous thromboembolism: a population-based study |
5 |
| TV viewing and incident venous thromboembolism: the Atherosclerotic Risk in Communities Study |
5 |
| Prothrombotic factors do not increase the risk of recurrent ischemic events after cryptogenic stroke at young age: the FUTURE study |
4 |
| Thrombosis in Philadelphia negative classical myeloproliferative neoplasms: a narrative review on epidemiology, risk assessment, and pathophysiologic mechanisms |
4 |
| microRNAs regulate nitric oxide release from endothelial cells by targeting NOS3 |
4 |
| Non-recommended dosing of direct oral anticoagulants in the treatment of acute pulmonary embolism is related to an increased rate of adverse events |
4 |
| Early therapeutic persistence on dabigatran versus warfarin therapy in patients with atrial fibrillation: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registry |
4 |
| Coronary artery fistulae |
4 |
| Thrombolysis in hemodynamically unstable patients: still underused: a review based on multicenter prospective registries on acute pulmonary embolism |
4 |
| Expanding anticoagulation management services to include direct oral anticoagulants |
4 |
